A new prognostic indicator for head and neck cancer--p53 serum antibodies?

Abstract

These results indicate that the occurrence of p53 antibodies does not correlate with the most relevant prognostic factors, rate of regional metastasis and primary tumor size, in patients with head and neck cancer.